p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1

Endocrinology

Volumn 139, Issue 3, 1998, Pages 1101-1107

  Ohlsson, Claes ^a,d   Kley, Nikolai ^b   Werner, Haim ^c   Leroith, Derek ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; CANCER CELL CULTURE; DNA TRANSFECTION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 0031769052     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.3.5832     Document Type: Article

References (44)

1. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
2. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL 1996 Repression of the insulin receptor promoter by the rumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 56:2781-2788
3. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R 1993 Simian virus 40 large rumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90:11217-11221
4. Baserga R 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252
5. LeRoith D, Werner H, Neuenschwander S, Kalebic T, Helman LJ 1995 The role of the insulin-like growth factor-I receptor in cancer. Ann NY Acad Sci 766:402-408
6. Parrizas M, Leroith D 1997 Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138:1355-1358
7. Parrizas M, Saltiel AR, LeRoith D 1997 Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272:154-161
8. McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M 1991 Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 78:921-929
9. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R 1996 A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 56:4013-4020
10. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R 1995 The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55:2463-2469
11. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R 1995 Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739-3741
12. Prisco M, Hongo A, Rizzo MG, Sacchi A, Baserga R 1997 The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 17:1084-1092
13. Werner H, Stannard B, Bach MA, LeRoith D, Roberts Jr CT 1990 Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem Biophys Res Commun 169:1021-1027
14. Cooke DW, Bankert LA, Roberts Jr CT, LeRoith D, Casella SJ 1991 Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem Biophys Res Commun 177:1113-1120
15. Mamula PW, Goldfine ID 1992 Cloning and characterization of the human insulin-like growth factor-I receptor gene 5′-flanking region. DNA Cell Biol 11:43-50
16. Werner H, Bach MA, Stannard B, Roberts Jr CT, LeRoith D 1992 Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 6:1545-1558
17. Werner H, Rauscher III FJ, Sukhatme VP, Drummond IA, Roberts Jr CT, LeRoith D 1994 Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269:12577-12582
18. Beitner-Johnson D, Werner H, Roberts Jr CT, LeRoith D 1995 Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element. Mol Endocrinol 9:1147-1156
19. Borellini F, Glazer RI 1993 Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J Biol Chem 268:7923-7928
20. Hollstein M, Sidransky D, Vogelstein B, Harris CC 1991 p53 mutations in human cancers. Science 253:49-53
21. Harris CC, Hollstein M 1993 Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327
22. Zambetti GP, Bargonetti J, Walker K, Prives C, Levine AJ 1992 Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev 6:1143-1152
23. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B 1992 Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830
24. Mack DH, Vartikar J, Pipas JM, Laimins LA 1993 Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281-283
25. Agoff SN, Hou J, Linzer DI, Wu B 1993 Regulation of the human hsp70 promoter by p53. Science 259:84-87
26. Werner H, Karnieli E, Rauscher FJ, LeRoith D 1996 Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 93:8318-8323
27. Fogh J, Wright WC, Loveless JD 1977 Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58:209-214
28. Buckbinder L, Talbott R, Seizinger BR, Kley N 1994 Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes. Proc Natl Acad Sci USA 91:10640-10644
29. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B 1990 Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915
30. Ueba T, Nosaka T, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, Oda Y, Kikuchi H, Hatanaka M 1994 Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc Natl Acad Sci USA 91:9009-9013
31. Andrews NC, Faller DV 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
32. Scatchard G 1949 The attractions of proteins to small molecules and ions. Ann NY Acad Sci 51:660-672
33. Rubini M, Hongo A, D'Ambrosio C, Baserga R 1997 The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp Cell Res 230:284-292
34. Baserga R 1994 Oncogenes and the strategy of growth factors. Cell 79:927-930
35. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher III FJ, Sens DA, Garvin AJ, LeRoith D, Roberts Jr CT 1993 Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 90:5828-5832
36. Werner H, Shen-Orr Z, Rauscher III FJ, Morris JF, Roberts Jr CT, LeRoith D 1995 Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor 1 receptor gene expression. Mol Cell Biol 15:3516-3522
37. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
38. Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ 1996 Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Cancer Res 56:1367-1373
39. Murphy M, Hinman A, Levine AJ 1996 Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 10:2971-2980
40. Findley HW, Gu L, Yeager AM, Zhou M 1997 Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 89:2986-2993
41. Gualberto A, Baldwin Jr AS 1995 p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J Biol Chem 270:19680-19683
42. Kraiss S, Quaiser A, Oren M, Montenarh M 1988 Oligomerization of oncoprotein p53. J Virol 62:4737-4744
43. Pascal E, Tjian R 1991 Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5:1646-1656
44. Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR, Robbins PD 1992 The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12:2455-2463